Explore
Trendline
Nanalysis Scientific Corp. Schedules First Quarter 2026 Conference Call to Discuss Financial Results
Nanalysis Scientific Corp. Schedules First Quarter 2026 Conference Call to Discuss Financial Results
Read More
Trendline
Imunon, Inc. Reports Increased Net Loss in Q1 2026 Amid Clinical Advancements
Imunon, Inc. Reports Increased Net Loss in Q1 2026 Amid Clinical Advancements
Read More
Trendline
Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call
Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call
Read More
Trendline
Ingredion Faces Earnings Decline Due to Sweetener Processing Issues at Argo Facility
Ingredion Faces Earnings Decline Due to Sweetener Processing Issues at Argo Facility
Read More
Trendline
TherapeuticsMD Reports Improved Financial Results and Strategic Exploration
TherapeuticsMD Reports Improved Financial Results and Strategic Exploration
Read More
Trendline
Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials
Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials
Read More
Trendline
Savara Reports Increased Losses in Q1 2026 Amid Regulatory Milestones for MOLBREEVI
Savara Reports Increased Losses in Q1 2026 Amid Regulatory Milestones for MOLBREEVI
Read More
Trendline
Manulife Announces Quarterly Dividend for Shareholders
Manulife Announces Quarterly Dividend for Shareholders
Read More
Trendline
cbdMD, Inc. Schedules Conference Call to Discuss Q2 2026 Financial Results
cbdMD, Inc. Schedules Conference Call to Discuss Q2 2026 Financial Results
Read More
Trendline
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Read More
Trendline
Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026
Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026
Read More
Trendline
Moderna Stock Fluctuates Amid Hantavirus Vaccine Development Concerns
Moderna Stock Fluctuates Amid Hantavirus Vaccine Development Concerns
Read More